Skip to main content
. 2017 Nov 11;8(62):105819–105831. doi: 10.18632/oncotarget.22402

Table 3. Summary of clinical and demographic features for study subjects and tumor characteristics.

CRC (55) EC (18) HC (40)
Stage-I/II Stage-III/IV p value
Age (median, range) 61, 27-84 59, 38-81 61, 32-77 59, 28-78
Sex 0.944
 Male 11 15 8 19
 Female 12 17 10 21
Cancer site
 Colon 10 23 0.034 -
 Rectum 13 9 -
Cervical 2 -
 Upper Thoracic 3 -
 Middle Thoracic 5 -
 Lower Thoracic 8 -
FOBT 0.767
 Positive 9 14 N/A N/A
 Negative 1 3 N/A N/A
 Not check 13 15
CEA (ng/mL) 0.029
 Positive 5 18 5 N/A
 Negative 15 11 3 N/A
 Not check 3 3
CA199(U/mL) 0.563
 Positive 3 8 3 N/A
 Negative 15 17 4 N/A
 Not check 5 7
Tumor size (cm, Mean ± SD)
 Major diameter 5.14±3.28 5.38±1.71 0.756
 Width diameter 3.90±2.08 4.21±1.52 0.573
 Thick diameter 1.92±1.14 2.38±1.21 0.119
Symptoms 0.184
 Change of stool character 10 18
 Hematochezia 12 10
 Abdominal pain 8 9
 Bowel obstruction 3 2
Weight 0.779
 <50kg 5 8
 ≥50kg 18 24